The Effectiveness of #Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial Background: Cognitive behavioral therapy (CBT) is recommended as the first-line treatment for insomnia; however, few patients have access to it. A new class of Food and Drug Administration (FDA)–regulated #Digital CBT treatments has the potential to address this unmet need. These treatments are ordered or prescribed by #Health care providers and are fully automated, delivering CBT directly to patients without human coaches. This trial builds upon promising earlier #Digital cognitive behavioral therapy for insomnia (CBT-I) research by using a decentralized design to recruit a sample with greater representation of the US general population, including individuals from lower socioeconomic status groups who often face greater barriers to care. Objective: This decentralized trial evaluated the effectiveness of a fully automated #Digital CBT-I program (SleepioRx) for treating insomnia disorder compared with online sleep hygiene education (SHE) in a sample of participants recruited from across the United States. Methods: A decentralized, parallel-group randomized controlled trial was conducted between November 2022 and August 2023. Participants were recruited nationally from across the United States, and a total of 336 adults aged 22 and older, diagnosed with the fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) insomnia disorder via structured clinical interview, were allocated 1:1 to either #Digital CBT-I (SleepioRx) or online SHE. The primary end points were insomnia severity, assessed using the Insomnia Severity Index (ISI), and sleep diary measures of sleep onset latency (SOL) and wake after sleep onset (WASO) at 10 weeks, with follow-up assessments at 16 and 24 weeks postrandomization. Results: Compared with SHE, SleepioRx showed statistically and clinically significant improvements on the ISI at posttreatment (10 weeks; Cohen d=0.60, P

JMIR Mental Health: The Effectiveness of #Digital Cognitive Behavioral Therapy to Treat Insomnia Disorder in US Adults: Nationwide Decentralized Randomized Controlled Trial #DigitalTherapy #CBT #InsomniaTreatment #MentalHealth #HealthCare

Deepak Chopra Had Meditation Sessions, Discussed Trump With Jeffrey Epstein - IndiaWest News Deepak Chopra Had Meditation Sessions, Discussed Trump With Jeffrey Epstein.

Deepak Chopra Had Meditation Sessions, Discussed Trump With Jeffrey Epstein

Full Story: indiawest.com/deepak-chopr...

#DeepakChopra #EpsteinConnection #MeditationMeetings #InsomniaTreatment #SpiritualHealing #TrumpTalks #ConsciousnessResearch #NewAgeGuru #LongevityScience

Chronic Insomnia Treatment: Brain Damage Risks & New Solutions Long-term poor sleep is more than just "stress." It's a condition known as chronic insomnia, and it may be inflicting serious damage on a much more critical organ: your brain. Finding the right chronic insomnia treatment is not just about feeling less tired; it's about protecting your long-term health.Do you find yourself exhausted after a long day, only to lie awake for hours? Do you finally fall asleep, but wake up at the slightest sound? This cycle of poor sleep often leads to extreme daytime

Chronic insomnia isn't just fatigue—it's linked to serious brain health risks.
Our new guide breaks down 3 treatment strategies + new medications.
Get the facts: zurl.co/iTVxe


#ChronicInsomnia #InsomniaTreatment #HealthGuide #MedicalTourismChina #ChinaMedicalTourism

Bedtime App-Guided Mindfulness Meditation in Patients With Insomnia: Mixed Methods Feasibility and Acceptability Pilot Study - PubMed Bedtime app-guided MM as an intervention in patients with insomnia and the hybrid study design with in-lab and at-home assessments are feasible and acceptable. This study informs the design of future ...

App-guided meditation for insomnia, though I'm a bit curious about why this is "app" guided instead of just using a recording.

#mindfulness #insomnia #insomniatreatment #bettersleep

pubmed.ncbi.nlm.nih.gov/41027036/

Asia Pacific Insomnia Market Size, Share, Growth Report 2032 Asia Pacific Insomnia Market growth is projected to reach USD 0.20 Billion, at a 8.12% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2024 to...

🌙🛌 Sleepless in APAC! Insomnia solutions rise as stress, screen time & urbanization spike sleep disorders.
#SleepHealth #InsomniaTreatment #AsiaHealth #MentalWellness

www.marketresearchfuture.com/reports/asia...

Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic Nxera Pharma Co., Ltd.

www.linkedin.com/pulse/nxera-...

Nxera and Shionogi Deliver Innovation with QUVIVIQ™ Launch, Targeting Japan's Insomnia Epidemic

kstrategyand.com/pharma-news

#NxeraPharma #Shionogi #QUVIVIQ #Daridorexant #InsomniaTreatment #SleepHealth #MentalHealthSupport #Humanteconomy #Humantec

Why choose OTC sleep aids? 🤔 They’re accessible, safe for short-term use, and effective for mild sleep disorders. Try melatonin to regulate your sleep cycle or calming lavender for natural relaxation! 🌱 #InsomniaTreatment #SleepMedicine
https://buff.ly/3TFaF4N